Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neoplasms × Genetic Testing × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Breast Neoplasms 3 Prostatic Neoplasms 2 Neoplastic Syndromes, Hereditary 2 Glioma 2 Colorectal Neoplasms 2 Tuberous Sclerosis 1 Thyroid Neoplasms 1 Sarcoma 1 Pheochromocytoma 1 Paraganglioma 1 Pancreatic Ductal Adenocarcinoma 1 Ovarian Neoplasms 1 Neoplasms, Unknown Primary 1 Neoplasms 1 Multiple Myeloma 1 Melanoma 1 Lymphoproliferative Disorders 1 Lymphangioleiomyomatosis 1 Kidney Neoplasms 1 Hereditary Breast and Ovarian Cancer Syndrome 1 Hematopoietic and Lymphatic System Neoplasm 1 Hematologic Neoplasms 1 Early Detection of Cancer 1 Colorectal Neoplasms, Hereditary Nonpolyposis 1 Carcinoma, Intraductal, Noninfiltrating 1 Brain Neoplasms 1 Bone Neoplasms 1 Anatomic Stage II Breast Cancer AJCC v8 1

Interventions

pembrolizumab 31 Blood Specimen Collection 29 Bevacizumab 18 Standard of Care 16 Radiotherapy 15 Carboplatin 14 Surveys and Questionnaires 13 Paclitaxel 13 Nivolumab 13 Exercise 13 Cisplatin 11 atezolizumab 10 Drug Therapy 10 Docetaxel 10 Dexamethasone 10 Cyclophosphamide 9 Pemetrexed 8 Fluorouracil 8 olaparib 7 Trastuzumab 7 Temozolomide 7 Leucovorin 7 Irinotecan 7 Interviews as Topic 7 Cetuximab 7 pertuzumab 6 Radiosurgery 6 Panitumumab 6 Oxaliplatin 6 Observation 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06008392 2025-10-10

INTERCEPTioN

Mayo Clinic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡